ILDONG HOLDINGS CO.,LTD  Logo

ILDONG HOLDINGS CO.,LTD

000230 | KO

Overview

Corporate Details

ISIN(s):
KR7000230003
LEI:
Country:
South Korea
Address:
서울특별시 서초구 바우뫼로27길 2 일동제약빌딩, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 129.0 KB
2025-09-11 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 44.3 KB
2025-08-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.8 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 2.1 MB
2025-07-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-30 00:00
M&A Activity
[기재정정]타법인주식및출자증권처분결정
Korean 21.5 KB
2025-07-30 00:00
Related Party Transaction
타법인주식및출자증권처분결정
Korean 15.8 KB
2025-07-28 00:00
Report Publication Announcement
결산실적공시예고(안내공시)
Korean 4.1 KB
2025-07-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 136.0 KB
2025-07-08 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 50.2 KB
2025-06-23 00:00
Related Party Transaction
타법인주식및출자증권처분결정
Korean 17.1 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 1015.5 KB
2025-05-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.9 MB
2025-05-12 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB

Automate Your Workflow. Get a real-time feed of all ILDONG HOLDINGS CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ILDONG HOLDINGS CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ILDONG HOLDINGS CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea
334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore
950210
Prestige Consumer Healthcare Inc. Logo
Develops and markets leading over-the-counter brands for personal healthcare and wellness.
United States of America
PBH
Prime Medicine, Inc. Logo
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America
PRME
Probi Logo
Develops and manufactures clinically proven probiotics for B2B supplement & nutrition partners.
Sweden
PROB
Develops scientifically validated probiotics for cardiometabolic health for consumers & partners.
United Kingdom
PBX
Processa Pharmaceuticals, Inc. Logo
Develops next-gen chemo and therapies for chronic and life-threatening diseases.
United States of America
PCSA
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea
296160
PROKIDNEY CORP. Logo
Develops cellular therapies to preserve kidney function for patients with advanced Chronic Kidney Disease.
United States of America
PROK
ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America
PRPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.